Background
A completed CDC study showing that COVID-19 vaccines cut hospitalizations and emergency department visits among healthy adults by roughly half has been blocked from publication in the agency's flagship scientific journal, according to three people with direct knowledge of the decision. The report had cleared the CDC's full internal scientific-review process, involving dozens of scientists, and had been scheduled for publication on March 19, 2026, in the Morbidity and Mortality Weekly Report (MMWR), a journal American public health officials have relied upon for more than 70 years.
What Happened
Acting CDC director Jay Bhattacharya first delayed it and, as of April 22, 2026, a formal rejection letter had been issued to the report's authors. Current and former CDC officials say it is extraordinarily rare for a fully reviewed paper to be blocked from publication.
Key Findings
The study used real-world data from the 2024-2025 season to evaluate the effectiveness of updated COVID-19 vaccines targeting Omicron sub-variants. Results showed that vaccinated healthy adults had a 49% lower risk of COVID-19-related hospitalization and a 45% lower risk of emergency department visits. These findings could have served as critical evidence for public health guidance, but were hindered by political interference.
Potential Implications
- Undermined scientific credibility: Such actions may erode public trust in vaccines and health agencies.
- Delayed public health decisions: Positive data could encourage vaccination uptake, especially among vulnerable populations.
- Warning of political interference in science: This incident highlights risks to scientific independence.
Expert Commentary
Public health experts argue that blocking this study may give the public a mistaken impression about vaccine safety and could damage U.S. leadership in global health. They call for a transparent investigation to ensure scientific decisions remain free from political influence.